Skip to main content

Market Overview

Why Zimmer Biomet's Stock Is Trading Higher Today

Why Zimmer Biomet's Stock Is Trading Higher Today

Zimmer Biomet Holdings Inc (NASDAQ: ZBH) shares are trading higher on Wednesday after SVB Leerink maintained a Buy rating on the stock and raised its price target from $136 to $146.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe and Japan.

Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.

Zimmer Biomet shares were trading up 5.50% at $131 during the time of publication on Wednesday. The stock has a 52-week high of $161.11 and a 52-week low of $74.37.

Latest Ratings for ZBH

May 2021BarclaysInitiates Coverage OnOverweight
May 2021JMP SecuritiesMaintainsMarket Outperform
May 2021Canaccord GenuityMaintainsBuy

View More Analyst Ratings for ZBH
View the Latest Analyst Ratings


Related Articles (ZBH)

View Comments and Join the Discussion!

Posted-In: why it's movingPrice Target Analyst Ratings

Latest Ratings

ATERRoth CapitalMaintains25.0
FMTXSVB LeerinkMaintains54.0
PLXSLoop CapitalMaintains105.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at